Amyloid is increasingly ceding ground in Alzheimer’s disease R&D to new approaches targeting inflammation, immune processes, ...
Morning Overview on MSN
Indiana University researchers just identified an enzyme called IDOL inside neurons — yanking it out cleared amyloid plaques and shielded brain cells from Alzheimer dam…
A team at Indiana University School of Medicine’s Stark Neurosciences Research Center has published findings showing that ...
Findings show lower amyloid PET positivity in Black and Latinx adults with cognitive impairment, highlighting disparities in ...
The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer’s disease. On its ...
The drug industry has been working on how to shuttle drugs through the blood-brain barrier, and the results will become ...
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly ...
Share on Pinterest Dopamine could potentially treat Alzheimer’s by stimulating the production of an enzyme that breaks down beta-amyloid plaques, researchers say. Qi Yang/Getty Images One of the ...
The Lancet World Report examines why regulators in the US, UK, and Europe have reached different decisions on new ...
C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a collaboration with SouthGenetics, a U.S.-based diagnostics company ...
Study reveals that lithium affects multiple cellular processes in Alzheimer's disease and opens up new avenues of research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results